ATF5 expression in invasive breast carcinoma subtypes (basal-like (triple negative), HER2+ non-luminal, Luminal A, and Luminal B) was also higher than that in the corresponding normal tissues (Figure S1A). Here, ERBB2 is linked to invasive breast carcinoma.